Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by FIACLE This..
Review of Myopia Management
November 12, 2024 INDIANAPOLIS — During the American Academy of Optometry’s 2024 Annual Meeting, CooperVision‘s Myopia Luminaries Forum coincided with the fifth anniversary of MiSight 1 day contact lenses earning FDA approval.* “Celebrating this five-year milestone with some of the brightest minds in the industry was a meaningful way to honor this journey,” said Justin Kwan, OD, FAAO, Head, Myopia Management, CooperVision.
VTI Shares Latest One-Year PROTECT Trial Data at Academy 2024
November 12, 2024 INDIANAPOLIS — At the American Academy of Optometry Meeting, Visioneering Technologies Inc. (VTI) shared new findings from Year One of the ongoing PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens) clinical trial. The PROTECT study, a randomized, double-masked, controlled clinical trial, evaluates the safety and effectiveness of NaturalVue Multifocal lenses for managing myopia progression in children.
Noteworthy Research From the 19th International Myopia Conference
October 10, 2024 Researchers in the field of myopia management from across the globe gathered in Hainan Island, China, for the International Myopia Conference from September 24 to September 28. Over the course of the conference, Review of Myopia Management highlighted many of the most important abstracts and posters that were presented at the event.
HOYA Presents Eight-Year Clinical Trial Results at IMC
October 7, 2024 HAINAN ISLAND, China — At the 19th International Myopia Conference, HOYA Vision Care shared the eight-year results from its ongoing clinical trial. The study is evaluating the long-term myopia control effect and user experience in patients wearing Defocus Incorporated Multiple Segments (DIMS) spectacle lenses.1 This is the longest clinical study conducted and presented on the MiYOSMART myopia management spectacle lenses worldwide.
Review of Myopia Management
October 7, 2024 BERLIN, Germany — Dopavision presented its six-month clinical trial data from its MyopiaX-1 trial at the 2024 International Myopia Conference. This first public presentation, delivered by Prof. Ian Flitcroft, DPhil, FRCOphth, Coordinating Investigator of the MyopiaX-1 trial, shared data supporting MyopiaX’s safety and signals of clinical effect on myopia progression over six months.
VTI Presents Latest PROTECT Trial Data at Myopia Conferences
October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study at both the International Myopia Conference and Vision By Design. Dr. Ashley Tuan, Chief Medical Officer at VTI, presented the findings at both events, highlighting results from an adjusted data analysis, complementing the previously shared unadjusted data.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with FIACLE
Contact FIACLE, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack